Related Experiment Video
Updated: Aug 31, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors
David G P van IJzendoorn1, Magdalena Matusiak1, Gregory W Charville1
1Department of Pathology, Stanford University School of Medicine, Stanford, California.
Tenosynovial giant cell tumor (TGCT) neoplastic cells resemble synoviocytes and lack CSF1R, suggesting current therapies may be ineffective. GFPT2 highlights these cells, pointing to new therapeutic targets like the YAP1/TAZ pathway.
Area of Science:
- Oncology
- Cell Biology
- Genomics
Background:
- Tenosynovial giant cell tumor (TGCT) involves neoplastic cells overproducing CSF1, stimulating bystander macrophages.
- An autocrine loop via CSF1R on neoplastic cells was hypothesized but unconfirmed.
Purpose of the Study:
- Investigate cellular interactions in TGCT using single-cell RNA sequencing (scRNA-seq).
- Characterize neoplastic cell populations and their molecular profiles.
- Identify potential therapeutic targets in TGCT.
Main Methods:
- scRNA-seq on 18,788 cells from TGCT and GCTB samples.
- Long-read RNA sequencing for TGCT samples.
- Immunofluorescence and immunohistochemistry (IHC) for validation.
Main Results:
- Identified two neoplastic cell populations in TGCT, similar to nonneoplastic synoviocytes.
- Discovered GFPT2 as a marker for TGCT neoplastic cells.
- Confirmed neoplastic cells lack CSF1R expression, challenging the autocrine loop hypothesis.
Conclusions:
- TGCT neoplastic cells are similar to synoviocytes and may not respond to CSF1R-targeted therapies.
- High GFPT2 expression correlates with YAP1/TAZ pathway activation.
- Platelet-derived growth factor receptor expression suggests novel therapeutic avenues.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Intracellular Signaling Affects Focal Adhesions
Some...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

